Advancing the standard of care with transformative technologies in regenerative aesthetics and reconstruction.
A Robust Product Platform for the Future
Tiger BioSciences is a leading provider of Human Cell and Tissue Products (HCT/P) that are specifically designed to support patients with natural, impactful solutions across multiple specialties.
Our HCT/P products are carefully developed and rigorously tested to provide the highest quality products and ensure compliance with regulatory standards. They are sourced from ethically obtained human cells and tissues and are processed and stored using state-of-the-art techniques to maintain their quality and consistency.
Our genuine gratitude goes out to all donors and donor families that decide to allow Tiger to be a steward of the gift of donation to change others’ lives. We’re committed to optimizing the usage of the gift, donated human tissue, that is entrusted to us by maximizing how tissues are being used across many different indications and applications.
Tiger Aesthetics is committed to staying ahead of the curve, constantly exploring new frontiers in tissue engineering and medical devices. We invest heavily in research and development, collaborating with leading academic institutions and partnering with industry pioneers to drive innovation and maximize the potential applications of human adipose tissue.
First to Market Tabbed Tissue Expander
First Shaped Implant to Market in US
First 5th generation High-Strength Cohesive Gel
First and only dual port tissue expander with an integrated drain
First and only company to offer a no-cost, 20-year implant warranty
First-and-only fat transfer system with a surfactant shown to enhance the survival of fat cells1
First FDA-cleared MRI-conditional breast tissue expander (shown with Tiger Aesthetics’s first FDA-cleared electronic port finder)
First Structural Adipose Filler designed for use in the body
- Medina MA 3rd, et al. Polymer therapy: a novel treatment to improve fat graft viability. Plast Reconstr Surg. 2011 Jun; 127(6):2270-2282. doi: 10.1097/PRS.0b013e3182139fc1. PMID: 21617461.
